Peptide · Investigational

Selank

An anxiolytic peptide used medically in Russia; unapproved elsewhere.

Key facts

  • Status: Investigational
  • Used for: Anxiety (Russia only)
  • Natural counterpart: An analog of tuftsin, a natural immune-regulating peptide.
  • Target enzyme / receptor: GABAergic & enkephalin systems (incompletely defined)
  • Signalling pathway: Modulates GABA/serotonin and immune signalling (mechanism not fully established)
    In plain terms: Thought to modulate calming GABA and serotonin signalling.
  • Crystal structure: no peptide–target complex in the PDB yet — study the target ↗

Status & safety

This peptide is investigational, or approved only in some regions — it is not a general consumer product. Treat online sellers with caution and speak to a clinician.

Research & clinical studies

Explore the biochemistry and clinical evidence for Selank — these open live, date-sorted searches, so they always show the latest.

Read research papers on PubMed ↗

Clinical studies (ClinicalTrials.gov) ↗ Google Scholar ↗ Related guide → All peptides & profiles →

Not medical advice. Chemdu is an educational resource and does not sell, prescribe or supply any peptide. Consult a licensed professional about any medicine or supplement.